The Effects of Different Ways of Dressing Central Line Associated Bloodstream Infections
1 other identifier
interventional
331
0 countries
N/A
Brief Summary
The goal of our study was to investigate whether different methods of dressing could lower catheter-associated bloodstream infections.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 20, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 3, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 3, 2017
CompletedFirst Submitted
Initial submission to the registry
October 18, 2017
CompletedFirst Posted
Study publicly available on registry
October 2, 2018
CompletedOctober 2, 2018
September 1, 2018
1.5 years
October 18, 2017
September 30, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Catheter-related blood stream infections density after dressing change
Confirm blood culture results and judge whether it is catheter related Bloodstream infection(CRBSI)
up to 18 months
Secondary Outcomes (1)
Central Line-Associated Bloodstream Infection density after dressing change
up to 18 months
Study Arms (2)
full sterile dressing
EXPERIMENTALPatients receive full sterile dressing
usual standard care
NO INTERVENTIONPatients receive usual standard care
Interventions
Replacement of the central venous catheters in the dressing process
Eligibility Criteria
You may qualify if:
- Adults older than 20 years old
- Patients with central venous catheters
- Agree to participate in this study, and fill out the study consent
You may not qualify if:
- PICC patients placed
- Patients with bloodstream infection
- Patients with immunocompromised patients (such as HIV, AIDS, pregnant, or cancer patients who are receiving chemotherapy or radiotherapy)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- STUDY CHAIR
Meng-lan Teng
National Taiwan University Hospital Hsin-Chu Branch
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head Nurse
Study Record Dates
First Submitted
October 18, 2017
First Posted
October 2, 2018
Study Start
August 20, 2015
Primary Completion
February 3, 2017
Study Completion
February 3, 2017
Last Updated
October 2, 2018
Record last verified: 2018-09
Data Sharing
- IPD Sharing
- Will not share